Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Research Medical Center · University of Florida · +6 more institutions
Abstract
No abstract available for this paper.
Citation impact
- FWCI
- 92.06
- Percentile
- 100%
- References
- 28
Authors
13- MJMichael J. ElmanCorresponding
Research Medical Center, University of Florida, Loma Linda University Health Care, Pain Management Center of Paducah, The Retina Center, Jaeb Center for Health Research, University of Florida Health Science Center, Florida College
- LPLloyd Paul Aiello
Research Medical Center, University of Florida, Loma Linda University Health Care, Pain Management Center of Paducah, The Retina Center, Jaeb Center for Health Research, University of Florida Health Science Center, Florida College
- RWRoy W. Beck
Research Medical Center, University of Florida, Loma Linda University Health Care, Pain Management Center of Paducah, The Retina Center, Jaeb Center for Health Research, University of Florida Health Science Center, Florida College
- NMNeil M. Bressler
Research Medical Center, University of Florida, Loma Linda University Health Care, Pain Management Center of Paducah, The Retina Center, Jaeb Center for Health Research, University of Florida Health Science Center, Florida College
- SBSusan B. Bressler
Research Medical Center, University of Florida, Loma Linda University Health Care, Pain Management Center of Paducah, The Retina Center, Jaeb Center for Health Research, University of Florida Health Science Center, Florida College
Topics & keywords
- Medicine
- Ranibizumab
- Triamcinolone acetonide
- Visual acuity
- Ophthalmology
- Randomized controlled trial
- Laser coagulation
- Endophthalmitis
- Good health and well-being